Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice - An isobolographic analysis

European Neuropsychopharmacology

Volumn 14, Issue 2, 2004, Pages 163-172

  Borowicz, Kinga K ^a   Łuszczki, Jarogniew ^a,c   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c Foundation for Polish Science   (Poland)

Author keywords

Antiepileptic drugs; Drug interactions; Etomidate; Ketamine; Maximal electroshock; Propofol

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETOMIDATE; KETAMINE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; EAR; ELECTRIC SHOCK; ELECTRODE; HINDLIMB; IMMUNOFLUORESCENCE; LEG MOVEMENT; LONG TERM MEMORY; MALE; MEMORY DISORDER; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TASK PERFORMANCE;

EID: 0842307065     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00104-4     Document Type: Article

References (46)

1. A-mediated inhibition in the rat hippocampal. Life Sci. 58:1996;2396-2407.
2. Anis N.A., Berry S.C., Burton N.R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79:1983;565-575.
3. Ashton D. Diazepam, pentobarbital and D-etomidate produced increases in bicuculline seizure threshold; selective antagonism in bicuculline seizure threshold; selective antagonism by RO15-1788, picrotoxin and (±)-DMBB. Eur. J. Pharmacol. 28:1983;319-325.
4. Batjer H.H., Frankfurt A.I., Michenfelder J.D. Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms. J. Neurosurg. 68:1988;234-240.
5. Black J.A., Golden G.T., Fariello R.G. Ketamine activation of experimental corticoreticular epilepsy. Neurology. 30:1980;315-318.
6. Boissier J.R., Tardy J., Diverres J.C. Une nouvelle methode simple pour explorer l'action'tranquilisante: le test de la cheminee. Med. Exp. (Basel). 3:1960;81-84.
7. Borowicz K.K., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur. J. Pharmacol. 323:1997;45-51.
8. Borowicz K.K., Kleinrok Z., Czuczwar S.J. Niguldipine impairs the protective of carbamazepine and phenobarbital in amygdala-kindled seizures in rats. Eur. Neuropsychopharmacol. 12:2002;225-233.
9. Borowicz K.K., Zadrożniak M., Świader M., Kowalska A., Kleinrok Z., Czuczwar S.J. Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures. Eur. J. Pharmacol. 449:2002;85-90.
10. Borris D.J., Bertram E.H., Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 42:2000;117-122.
11. Bowyer J.F., Albertson T.E., Winters W.D. Cortical kindled seizures: modification by excitant and depressant drugs. Epilepsia. 24:1983;356-367.
12. Czuczwar S.J., Kleinrok Z., Turski W.A. Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs. CNS Drug Rev. 2:1996;452-467.
13. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P.N., Renier W.O., Van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia. 41:2000;1364-1374.
14. DeGiorgio C.M., Tomiyasu U., Gott P.S., Treiman D.M. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia. 33:1992;23-27.
15. De Riu P.L., Petruzzi V., Testa C., Mulas M., Melis F., Caria M.A., Mameli O. Propofol anticonvulsant activity in experimental epileptic status. Br. J. Anaesth. 69:1992;177-181.
16. Duysens J., Inoue M., Van Luijtelaar E.L., Dirksen R., Coenen A.M. Facilitation of spike-wave activity by the hypnotic etomidate in a rat model for absence epilepsy. Int. J. Neurosci. 57:1991;213-217.
17. Friederich P., Trellakis S., Urban B.W. Epileptic seizures from etomidate? The human Kv1.1 potassium channel in humans. Anesth. Int. Notf. Schm. 36:2001;100-104.
18. Funahashi M., Higuchi H., Miyawaki T., Shimada M., Matsuo R. Propofol suppresses a hyperpolarization-activated inward current in rat hippocampal CA1 neurons. Neurosci. Lett. 311:2001;177-180.
19. Hill-Venning C., Belelli D., Peters J.A., Lambert J.J. Subunit-dependent interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor. Br. J. Pharmacol. 120:1997;749-756.
20. Inoue Y., Shibuya I., Kabashima N., Noguchi J., Harayama N., Ueta Y., Sata T., Shigematsu A., Yamashita H. The mechanism of inhibitory actions of propofol on rat supraoptic neurons. Anesthesiology. 91:1999;167-178.
21. Kounenis G., Koutsoviti-Papadopoulou M., Elezoglou V. Ketamine may modify intestinal motility by acting at GABA(A) receptor complex; an in vitro study on the guinea pig intestine. Pharmacol. Res. 31:1995;337-340.
22. Krasowski M.D., Jenkins A., Flood P., Kung A.Y., Hopfinger A.J., Harrison N.L. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J. Pharmacol. Exp. Ther. 297:2001;338-351.
23. A receptors by endogenous and synthetic neuroactive steroids. Brain Res. Rev. 37:2001;68-80.
24. Lee V.C., Moscicki J.C., DiFazio C.A. Propofol sedation produces dose-dependent suppression of lidocaine-induced seizures in rats. Anesth. Analg. 86:1998;652-657.
25. Lee J.H., Kim D., Hong H.N., Han S.M., Kim J.U. Protective effect of etomidate on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci. Lett. 286:2000;179-182.
26. Lees G.J. Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus. Neuropharmacology. 34:1995;411-417.
27. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
28. Lowson S., Gent J.P., Goodchild C.S. Convulsive thresholds in .mice during the recovery phase from anaesthesia induced by propofol, thiopentone, methohexitone and etomidate. Br. J. Pharmacol. 102:1991;879-882.
29. Luszczki J., Borowicz K.K., Świader M., Czuczwar S.J. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice - an isobolographic analysis. Epilepsia. 44:2003;489-499.
30. A receptor channels. Annu. Rev. Neurosci. 17:1994;569-602.
31. Milde L.N., Milde J.H., Michenfelder J.D. Cerebral function, metabolic and hemodynamic effects of etomidate in dogs. Anesthesiology. 73:1985;371-377.
32. Modica P.A., Tempelhoff R., White P.F. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth. Analg. 70:1990;433-444.
33. Momota Y., Artu A.A., Powers K.M., Mautz D.S. Posttreatment with propofol terminates lidocaine-induced epileptiform electroencephalogram activity in rabbits: effects on cerebrospinal fluid dynamics. Anesth. Analg. 87:1999;900-906.
34. Orser B.A., Pennefather P.S., MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 86:1997;903-917.
35. Patel P.M., Goskowicz R.L., Drummond J.C., Cole D.J. Etomidate reduces ischemia-induced glutamate release in the hippocampus in rats subjected to incomplete forebrain ischemia. Anesth. Analg. 80:1995;933-999.
36. Reder B.S., Trapp L.D., Troutman K.C. Ketamine suppression of chemically-induced convulsions in the two-day-old white leghorn cockerel. Anesth. Analg. 59:1980;406-409.
37. Rehberg B., Duch D.S. Suppression of central nervous system sodium channels by propofol. Anesthesiology. 91:1999;512-520.
38. Sanna E., Motzo C., Usala M., Serra M., Dazzi L., Maciocco E., Trapani G., Latrofa A., Liso G., Biggio G. Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties. Br. J. Pharmacol. 126:1999;1444-1454.
39. Sharma A.C., Thorat S.N., Nayar U., Kulkarni S.K. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice. Indian J. Physiol. Pharmacol. 35:1991;111-116.
40. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain. 49:1992;93-97.
41. Trommer B.L., Pasternak J.F. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats. Brain Res. 53:1990;248-252.
42. Urbanska E., Dziki M., Kleinrok Z., Czuczwar S.J., Turski W.A. Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur. J. Pharmacol. 200:1991;277-282.
43. Venault P., Chapouthier G., De Carvalho L.P., Simiand J., Morre M., Dodd R.H., Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature. 321:1986;864-866.
44. Williamson J.M., Lothman E.W. The effect of MK-801 on kindled seizures: implications for use and limitations as an antiepileptic drug. Ann. Neurol. 26:1989;85-90.
45. Yamakura T., Sakimura K., Shimoji K., Mishina M. Effects of propofol on various AMPA-, kainate-and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci. Lett. 188:1995;187-190.
46. Yeoman P., Hutchinson A., Byrne A., Smith J., Durham S. Etomidate infusions for the control of the refractory status epilepticus. Intensive Care Med. 15:1989;255-259.